Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $6.3 million.

  • Cellebrite DI's Other Non-Current Assets fell 1762.93% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 1762.93%. This contributed to the annual value of $7.7 million for FY2024, which is 464.51% up from last year.
  • Latest data reveals that Cellebrite DI reported Other Non-Current Assets of $6.3 million as of Q3 2025, which was down 1762.93% from $6.7 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Other Non-Current Assets high stood at $8.2 million for Q2 2024, and its period low was $179000.0 during Q3 2021.
  • Over the past 5 years, Cellebrite DI's median Other Non-Current Assets value was $6.3 million (recorded in 2025), while the average stood at $4.7 million.
  • Per our database at Business Quant, Cellebrite DI's Other Non-Current Assets soared by 91955.31% in 2022 and then plummeted by 1868.92% in 2025.
  • Cellebrite DI's Other Non-Current Assets (Quarter) stood at $2.0 million in 2021, then dropped by 11.59% to $1.7 million in 2022, then soared by 324.09% to $7.3 million in 2023, then rose by 4.65% to $7.7 million in 2024, then decreased by 18.13% to $6.3 million in 2025.
  • Its Other Non-Current Assets was $6.3 million in Q3 2025, compared to $6.7 million in Q2 2025 and $6.9 million in Q1 2025.